HomeNewscoronavirusChildren with mild COVID-19 can still develop long-term symptoms: Study

Children with mild COVID-19 can still develop long-term symptoms: Study

The research, published in The Pediatric Infectious Disease Journal, examined data from volunteers between the ages of 5 and 18 across the state of Texas, US.

August 11, 2022 / 15:28 IST
Story continues below Advertisement
Representative image
Representative image

Children infected with the SARS-CoV-2 virus, but not hospitalised, can still experience long COVID symptoms up to three months past infection, according to a study. The research, published in The Pediatric Infectious Disease Journal, examined data from volunteers between the ages of 5 and 18 across the state of Texas, US.

The volunteers were enrolled in the Texas CARES survey, which began in October of 2020 with the goal of assessing COVID-19 antibody status over time among a population of adults and children in Texas. Data for this study was collected before and after the vaccine rollout and during the waves of the Delta and Omicron variants.

Story continues below Advertisement

"We were interested in understanding if children impacted with an acute or severe infection of COVID-19 would go on to have persisting symptoms, or what we call long COVID," said Sarah Messiah, first author of the study and professor at the University of Texas Health Science Center. This particular study is unique as the first population-based study in literature to report on prevalence of long COVID in children who have not been hospitalised with COVID-19," Messiah said.

A total of 82 pediatric volunteers (4.8 percent of the total 1,813) reported having long COVID symptoms, the researchers said. About 1.5 percent showed symptoms that lasted between four and 12 weeks, including loss of taste and smell, fatigue, and cough, they said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show